The receptor for advanced glycation end-products (RAGE) is a multiligand binding and single-pass transmembrane protein which actively participates in several chronic inflammation-related diseases. RAGE, in addition to AGEs, has a wide repertoire of ligands, including several damage-associated molecular pattern molecules or alarmins such as HMGB1 and members of the S100 family proteins. Over the last years, a large and compelling body of evidence has revealed the active participation of the RAGE axis in tumor biology based on its active involvement in several crucial mechanisms involved in tumor growth, immune evasion, dissemination, as well as by sculpturing of the tumor microenvironment as a tumor-supportive niche. In the present review, we will detail the consequences of the RAGE axis activation to fuel essential mechanisms to guarantee tumor growth and spreading.
Skip Nav Destination
Review Article| June 21 2022
The RAGE/multiligand axis: a new actor in tumor biology.
- Views Icon Views
- Share Icon Share
Armando Rojas, Iván Schneider, Cristian Lindner, Ileana González, Miguel A. Morales; The RAGE/multiligand axis: a new actor in tumor biology.. Biosci Rep 2022; BSR20220395. doi: https://doi.org/10.1042/BSR20220395
Download citation file: